Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-May-15 7:03 PM View:  | Ubben Jeffrey W Director | Valeant Pharmaceuticals Int... (VRX) | 26-May-15 | Payment of Exercise | 124 | $224.63 | $27,854.10 | (< 1%) 19.39M to 19.39M | 90% |
| 27-May-15 7:03 PM View: | Ubben Jeffrey W Director | Valeant Pharmaceuticals Int... (VRX) | 22-May-15 | Grant | 1,607 | -- | -- | < 1% 19.39M to 19.39M | |
| 30-Sep-10 8:36 PM View: | Ingram Robert Alexander Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 79,053 | -- | -- | (100%) 79.05K to 0 | |
| 30-Sep-10 8:34 PM View: | Stefano Stephen F. Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 10,902 | -- | -- | (100%) 10.9K to 0 | |
| 20-Oct-10 5:56 PM View: | Min Steve T. EVP, General Counsel | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 213,069 | -- | -- | (100%) 213.07K to 0 | |
| 30-Sep-10 8:35 PM View: | Melas Kyriazi Theo Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 60,627 | -- | -- | (100%) 60.63K to 0 | |
| 30-Sep-10 8:37 PM View: | Koppes Richard Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 54,523 | -- | -- | (100%) 54.52K to 0 | |
| 30-Sep-10 8:53 PM View: | Valueact Holdings, L.P. 10% Owner | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 15,163,000 | -- | -- | (100%) 15.16M to 0 | |
| 20-Oct-10 5:52 PM View: | Karlson Elisa A. EVP, Chief Admin Officer | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 218,663 | -- | -- | (100%) 218.66K to 0 | |
| 20-Oct-10 5:59 PM View: | Blott Peter J EVP, Chief Financial Officer | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 216,889 | -- | -- | (100%) 216.89K to 0 | |
| 30-Sep-10 8:34 PM View: | Lonner Anders Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 12,766 | -- | -- | (100%) 12.77K to 0 | |
| 20-Oct-10 5:49 PM View: | Chaudhuri Bhaskar President | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 333,438 | -- | -- | (100%) 333.44K to 0 | |
| 20-Oct-10 5:55 PM View: | Pearson J. Michael CEO and Chairman | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 1,931,500 | -- | -- | (100%) 1.93M to 0 | |
| 30-Sep-10 8:40 PM View: | Kugelman Larry Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 55,589 | -- | -- | (100%) 55.59K to 0 | |
| 20-Oct-10 6:00 PM View: | de Silva Rajiv Chief Operating Officer | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 261,994 | -- | -- | (100%) 261.99K to 0 | |
| 30-Sep-10 8:39 PM View: | Provencio Norma Ann Director | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 39,574 | -- | -- | (100%) 39.57K to 0 | |
| 24-Aug-10 7:29 PM View: | de Silva Rajiv Chief Operating Officer | Valeant Pharmaceuticals Int... (VRX) | 24-Aug-10 | Payment of Exercise | 2,387 | $57.02 | $136,107.00 | (2%) 96.49K to 94.1K | (2%) |
| 06-Jul-10 7:47 PM View: | Koppes Richard Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 153 | -- | -- | < 1% 30.39K to 30.54K | |
| 06-Jul-10 7:48 PM View: | Lonner Anders Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 320 | -- | -- | 3% 12.45K to 12.77K | |
| 06-Jul-10 7:47 PM View: | Kugelman Larry Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 357 | -- | -- | < 1% 37.25K to 37.61K | |
| 06-Jul-10 7:48 PM View: | Provencio Norma Ann Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 406 | -- | -- | < 1% 45.21K to 45.62K | |
| 06-Jul-10 7:46 PM View: | Ingram Robert Alexander Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 345 | -- | -- | < 1% 42.52K to 42.86K | |
| 06-Jul-10 7:48 PM View: | Stefano Stephen F. Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 135 | -- | -- | < 1% 19.57K to 19.71K | |
| 06-Jul-10 7:48 PM View: | Melas Kyriazi Theo Director | Valeant Pharmaceuticals Int... (VRX) | 01-Jul-10 | Grant | 369 | -- | -- | < 1% 47.28K to 47.65K | |
| 01-Jul-10 7:52 PM View: | Min Steve T. EVP and General Counsel | Valeant Pharmaceuticals Int... (VRX) | 30-Jun-10 | Payment of Exercise | 1,037 | $52.29 | $54,224.70 | (2%) 60.95K to 59.91K | (11%) |
| 11-Jun-10 5:57 PM View: | de Silva Rajiv Chief Operating Officer | Valeant Pharmaceuticals Int... (VRX) | 09-Jun-10 | Market Option Sale | 23,000 | $45.24 | $1,040,570.00 | (19%) 119.49K to 96.49K | (29%) |
| 11-Jun-10 5:57 PM View: | de Silva Rajiv Chief Operating Officer | Valeant Pharmaceuticals Int... (VRX) | 09-Jun-10 | Option Exercise | 23,000 | $22.68 | $521,640.00 | 24% 96.49K to 119.49K | |
| 13-May-10 1:03 PM View: | Lonner Anders Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 27% 9.77K to 12.45K | |
| 13-May-10 2:44 PM View: | Valueact Holdings, L.P. 10% Owner | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant Duplicate | 2,677 | -- | -- | < 1% 15.16M to 15.16M | |
| 13-May-10 1:03 PM View: | Kugelman Larry Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 8% 34.57K to 37.25K | |
| 13-May-10 1:04 PM View: | Provencio Norma Ann Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 6% 42.53K to 45.21K | |
| 13-May-10 1:02 PM View: | Ingram Robert Alexander Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 3,500 | -- | -- | 9% 39.02K to 42.52K | |
| 13-May-10 1:05 PM View: | Stefano Stephen F. Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 16% 16.89K to 19.57K | |
| 13-May-10 1:04 PM View: | Melas Kyriazi Theo Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 6% 44.6K to 47.28K | |
| 13-May-10 1:03 PM View: | Koppes Richard Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 10% 27.71K to 30.39K | |
| 13-May-10 2:27 PM View: | Morfit G Mason Director | Valeant Pharmaceuticals Int... (VRX) | 11-May-10 | Grant | 2,677 | -- | -- | 12% 22.01K to 24.69K | |
| 04-May-10 2:37 PM View: | Valueact Holdings, L.P. 10% Owner | Valeant Pharmaceuticals Int... (VRX) | 30-Apr-10 | Market Sale | 2,637,540 | $40.41 | $106,583,000.00 | (15%) 17.78M to 15.14M | (44%) |
| 07-Apr-10 7:02 PM View: | Karlson Elisa A. EVP & Chief Administrative | Valeant Pharmaceuticals Int... (VRX) | 07-Apr-10 | Payment of Exercise | 1,635 | $44.05 | $72,021.80 | (2%) 84.14K to 82.5K | (32%) |
| 05-Apr-10 7:11 PM View: | Ingram Robert Alexander Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 405 | -- | -- | 1% 38.61K to 39.02K | |
| 05-Apr-10 7:13 PM View: | Stefano Stephen F. Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 201 | -- | -- | 1% 16.69K to 16.89K | |
| 05-Apr-10 7:12 PM View: | Melas Kyriazi Theo Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 434 | -- | -- | < 1% 44.17K to 44.6K | |
| 05-Apr-10 7:12 PM View: | Koppes Richard Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 180 | -- | -- | < 1% 27.53K to 27.71K | |
| 05-Apr-10 7:12 PM View: | Lonner Anders Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 376 | -- | -- | 4% 9.39K to 9.77K | |
| 05-Apr-10 7:12 PM View: | Kugelman Larry Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 419 | -- | -- | 1% 34.16K to 34.57K | |
| 05-Apr-10 7:13 PM View: | Provencio Norma Ann Director | Valeant Pharmaceuticals Int... (VRX) | 01-Apr-10 | Grant | 476 | -- | -- | 1% 42.06K to 42.53K | |
| 18-Mar-10 7:20 PM View: | Blott Peter J EVP & CFO | Valeant Pharmaceuticals Int... (VRX) | 16-Mar-10 | Payment of Exercise | 436 | $39.86 | $17,379.00 | (< 1%) 90.92K to 90.49K | (46%) |
| 02-Mar-10 3:10 PM View: | Stefano Stephen F. Director | Valeant Pharmaceuticals Int... (VRX) | 01-Mar-10 | Market Purchase | 3,300 | $37.28 | $123,024.00 | 25% 13.39K to 16.69K | 56% |
| 03-Feb-10 3:18 PM View: | Pearson J. Michael CEO and Chairman of the Board Director | Valeant Pharmaceuticals Int... (VRX) | 01-Feb-10 | Payment of Exercise | 31,840 | $33.72 | $1,073,640.00 | (3%) 1.04M to 1.0M | (73%) |
| 22-Jan-10 2:21 PM View: | de Silva Rajiv Chief Operating Officer | Valeant Pharmaceuticals Int... (VRX) | 21-Jan-10 | Payment of Exercise | 2,143 | $34.27 | $73,440.60 | (2%) 98.63K to 96.49K | (70%) |
| 05-Jan-10 5:56 PM View: | Lonner Anders Director | Valeant Pharmaceuticals Int... (VRX) | 04-Jan-10 | Grant | 512 | -- | -- | 6% 8.88K to 9.39K |
